LILRA3

LILRA3

Target · Soluble immunoreceptor

LILRA3 Leukocyte immunoglobulin like receptor A3 · CD85e

LILRA3 (leukocyte immunoglobulin like receptor A3, also known as CD85e, LIR-4, ILT6, HM31 and HM43) is a secreted member of the leukocyte immunoglobulin-like receptor family. It acts as a soluble receptor for class I MHC antigens. Browse Assay Genie's current range of LILRA3 research reagents below, or read on for the biology behind the target.

Secreted proteinSoluble MHC class I receptorGene deletion polymorphism
439 aa
Protein length
~47 kDa
Molecular weight
19q13.4 alternate reference locus
Gene locus
LILR family
Protein family
Target information

What is LILRA3 (leukocyte immunoglobulin like receptor A3)?

LILRA3 functions as a soluble receptor for class I MHC antigens. It binds both classical and non-classical HLA class I molecules, although with reduced affinities compared with LILRB1 or LILRB2. UniProt also reports that it binds with high affinity to the surface of monocytes, leading to abolition of LPS-induced TNF production by these cells.

The LILRA3 gene encodes a member of a family of immunoreceptors expressed predominantly in monocytes and B cells, and at lower levels in dendritic cells and natural killer cells. Unlike other members of the family, the encoded protein lacks a transmembrane region, which is consistent with its secreted localisation. Alternatively spliced transcript variants encoding different isoforms have been described.

The LILRA3 gene lies within a cluster of related genes on chromosome 19 and is polymorphic in human populations, with many individuals carrying a deletion of this genomic region. HGNC places the protein in the CD molecules group and among the activating leukocyte immunoglobulin like receptors. Its previous name, leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3, reflects the absence of the transmembrane domain.

MHC class I recognition

LILRA3 binds classical and non-classical HLA class I molecules as a soluble receptor, making it a useful subject for studying MHC class I recognition.

Monocyte biology

LILRA3 binds the monocyte surface with high affinity and abolishes LPS-induced TNF production, linking it to the regulation of monocyte responses.

Immunoreceptor family comparisons

Its reduced HLA class I affinity relative to LILRB1 and LILRB2 allows comparison of binding behaviour across leukocyte immunoglobulin-like receptors.

Human genetic variation

The gene is polymorphic and often deleted in individuals, which makes it relevant to studies of genetic variation in the chromosome 19 receptor cluster.

Background

LILRA3 frequently asked questions

What does LILRA3 do?

LILRA3 acts as a soluble receptor for class I MHC antigens. It binds classical and non-classical HLA class I molecules with lower affinity than LILRB1 or LILRB2, and binds the monocyte surface with high affinity, which abolishes LPS-induced TNF production by monocytes.

What other names and isoforms does LILRA3 have?

LILRA3 is also called CD85e, LIR-4, LIR4, ILT6, HM31 and HM43. Its previous HGNC name described it as a subfamily A member without a TM domain. Alternatively spliced transcript variants encoding different isoforms have been reported.

Is LILRA3 the same in all people?

No. The LILRA3 gene is polymorphic in human populations, and many individuals carry a deletion of this genomic region within a cluster of related genes on chromosome 19. No mouse or rat ortholog is listed in the data here; check the datasheet of any product for its validated reactivity.

Explore

Related targets

Other activating leukocyte immunoglobulin-like receptors in the same family, with products at Assay Genie.

Gene and protein annotations from HGNC, NCBI Gene and UniProt Q8N6C8; product specifications from Assay Genie datasheets.

LILRA3 Product listing